Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
When insurance denies brand-name coverage, paying $199 monthly out-of-pocket for compounded semaglutide beats paying $969 or $1,349 for brand-name versions
Semaglutidesold as Ozempic, Wegovy, and Rybelsusquickly rose to become the most common GLP-1 drug prescribed since its introduction to market in 2018
Personal Stories: Real Patients, Real Results Mark decided to try compounded GLP-1 therapy
Retatrutide, a newer triple agonist targeting GIP, GLP-1, and glucagon receptors, has a half-life of approximately six days
Will I Still Need Surgery
US$ 20.40
US$ 21.64
US$ 21.46
US$ 24.38
US$ 29.29
